Chemoinformaics analysis of 1-((4-METHOXYPHENYL)METHYL)-2-METHYL-5,6,7-TRIMETHOXYISOQUINOLINIUM IODIDE
| Molecular Weight | 481.33 | nRot | 6 |
| Heavy Atom Molecular Weight | 457.138 | nRig | 17 |
| Exact Molecular Weight | 481.075 | nRing | 3 |
| Solubility: LogS | -4.582 | nHRing | 1 |
| Solubility: LogP | 3.475 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 51 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 17 |
| nHA | 4 | APOL | 60.731 |
| nHD | 0 | BPOL | 32.731 |
| QED | 0.637 |
| Synth | 2.504 |
| Natural Product Likeliness | 0.651 |
| NR-PPAR-gamma | 0.217 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.999 |
| HIA | 0.05 |
| CACO-2 | -4.738 |
| MDCK | 0.0000367 |
| BBB | 0.921 |
| PPB | 0.745161 |
| VDSS | 1.331 |
| FU | 0.14522 |
| CYP1A2-inh | 0.128 |
| CYP1A2-sub | 0.951 |
| CYP2c19-inh | 0.175 |
| CYP2c19-sub | 0.946 |
| CYP2c9-inh | 0.037 |
| CYP2c9-sub | 0.778 |
| CYP2d6-inh | 0.655 |
| CYP2d6-sub | 0.902 |
| CYP3a4-inh | 0.114 |
| CYP3a4-sub | 0.921 |
| CL | 9.623 |
| T12 | 0.548 |
| hERG | 0.195 |
| Ames | 0.322 |
| ROA | 0.135 |
| SkinSen | 0.227 |
| Carcinogencity | 0.184 |
| EI | 0.244 |
| Respiratory | 0.473 |
| NR-Aromatase | 0.493 |
| Antiviral | Yes |
| Prediction | 0.758683 |